CVS Health Corporation $CVS Shares Sold by Townsquare Capital LLC

Townsquare Capital LLC trimmed its stake in shares of CVS Health Corporation (NYSE:CVS) by 19.7% in the 3rd quarter, HoldingsChannel reports. The firm owned 28,696 shares of the pharmacy operator’s stock after selling 7,026 shares during the quarter. Townsquare Capital LLC’s holdings in CVS Health were worth $2,163,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of CVS. Harbor Capital Advisors Inc. boosted its holdings in shares of CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 142 shares during the period. Avion Wealth lifted its position in shares of CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 189 shares in the last quarter. Corundum Trust Company INC acquired a new position in CVS Health in the 3rd quarter worth approximately $29,000. Harbor Asset Planning Inc. purchased a new position in CVS Health during the 2nd quarter worth approximately $30,000. Finally, Front Row Advisors LLC raised its stake in CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 371 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Up 0.4%

CVS stock opened at $74.33 on Friday. The firm has a market cap of $94.35 billion, a PE ratio of 195.61, a PEG ratio of 0.68 and a beta of 0.48. CVS Health Corporation has a 1 year low of $53.36 and a 1 year high of $85.15. The company has a fifty day simple moving average of $78.97 and a 200 day simple moving average of $75.01. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business’s revenue was up 7.8% compared to the same quarter last year. During the same period last year, the company earned $1.09 earnings per share. Sell-side analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.6%. The ex-dividend date is Thursday, January 22nd. CVS Health’s payout ratio is presently 700.00%.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on CVS shares. Morgan Stanley lifted their price target on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. UBS Group reaffirmed an “outperform” rating on shares of CVS Health in a research note on Wednesday, December 10th. Weiss Ratings reissued a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 29th. Wells Fargo & Company lowered their price objective on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a research report on Thursday, November 13th. Finally, Evercore ISI lifted their target price on shares of CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Nineteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $94.82.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.